We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on new technology integration in the field of bioanalysis.
Single molecule counting (SMC™) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/mL levels, allowing researchers to identify new biomarkers or assist in therapeutic development with an improved view of efficacy, safety and time course studies. Find out more in this video webinar from Millipore Sigma (MA, USA).
Available to view on demand.
In this free panel discussion, our experts will provide insights into their own research with large molecules including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field. There is also an opportunity for your own questions to be answered in the live Q&A.
Learn about new UHPLC column technologies and how to exploit them for improved characterization of biomacromolecules in our free upcoming webinar!
View webinar on demand
How we can use the Xevo Mass Spectrometer, combined with immunoaffinity extraction to provide a premium sensitivity assay for our clients and help them drive forward the development of insulin molecules and their biosimilars? – Available on demand
View webinar on demand.
This webinar will highlight recent advances in metabolomics for pharmaceutical research, drug development and precision medicine.
Researchers have developed an organ-on-a-chip that could aid the understanding of premature births as it replicates the functions of the placenta membrane.
In this editorial, the theme for the 2018 Reid workshop is discussed: ‘Challenges Associated with Large Molecules using Chromatography’. The event is an opportunity for new or early-career scientists, or those wishing to expand their skills base, to learn from experts from industry and academia.
This week’s round-up includes the discovery of a novel method for mass spectometry and thermal desorption, as well as an update from Waters Corp (MA, USA) on their aquisition of DESI technology exclusive rights.
In this podcast, Kevin Ray (MilliporeSigma) discusses the techniques and technologies utilized in drug metabolism studies for biotherapeutics, and what he believes the future holds for the field.
As part of our focus, we present this podcast where we talk to Mark Savage who discusses how software tools can address certain challenges and bring forward compounds from discovery to development.
In this editorial, Timothy Sikorski (GSK; PA, USA), discusses particular considerations for developing and validating LC–MS biomarker assays using the surrogate peptide approach.